Ozempic, GLP-1s May Help Curb Substance Use Disorders, UTEP Study Finds Significantly lower rates of alcohol, nicotine, opioid and cocaine use disorders found among patients taking GLP-1 medications EL PASO, Texas (June 8, 2026) A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders
Behavioral Therapy: Addressing the emotional and psychological aspects of weight management
ColonBroom GLP-1 Booster is a dietary supplement
In the vast majority of cases, yesbody aches resolve naturally within 14 weeks as your metabolism fully adjusts and inflammation subsides
Experts raise concerns about using unapproved versions of these medications, which may have different active ingredients or dosing issues